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Abstract Phosphate shows a non-competitive inhibition toward
a Streptomyces aminopeptidase (sAP) between pH 5.85
(Ki = 0.48 mM) and 9.0 (110 mM), with a pKa of 7.1 likely
due to ionization of H2PO34 . This non-competitive inhibition
pattern indicates that phosphate binding to sAP in solution is
different from that in the crystal structure, where phosphate is
bound to the active site Zn(II) ions. Fluoride uncompetitively
inhibits sAP from pH 5.5 (Ki = 3.72 mM) to 9.0 (43.6 mM), with
a pKa of V6.2 likely due to a coordinated water. The different
inhibition natures and pKa values indicate that the two inhibitors
bind at different locations.
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1. Introduction
Aminopeptidases (APs) catalyze the hydrolysis of protein or
peptide substrates from the N-terminus, and are widely dis-
tributed throughout nature in bacteria, plants, and mamma-
lian tissue [1^3]. Several biological processes, such as protein
maturation, terminal degradation of proteins, and hormone
level regulation require aminopeptidases to function properly
[1^3]. Altered aminopeptidase activity has been associated
with several pathological disorders and diseases, which in-
volve cancer [4], AIDS [5], and eye lens cataracts [6,7].
The AP from Aeromonas proteolytica (aAP) has two zinc
ions in its active site 3.5 Aî apart, bridged by an aspartate and
a water molecule [8]. A crystal structure of an inhibitor-bound
(D-iodophenylalanine hydroxamate) complex of this enzyme
[9] has allowed a mechanism similar to that of thermolysin
and carboxypeptidase A to be proposed [10,11], in which a
carboxylate (Glu-151) in the active site of aAP appears to
form a hydrogen bond with the bridging oxygen of the inhib-
itor. A £uoride inhibition study on aAP revealed that the
anion inhibits uncompetitively and displaces one metal-bound
water or hydroxide after substrate binding [12]. Bovine lens
leucine aminopeptidase (blAP) has also been characterized by
means of X-ray crystallography. Its active site contains two
zinc ions 2.9 Aî apart, bridged by a bidentate glutamate, a
monodentate aspartate, and a hydroxide [13]. Crystal struc-
tures of blAP-inhibitor complexes allowed a reaction mecha-
nism to be proposed for this enzyme [14^17]. In this mecha-
nism, the N-terminal amino group of the substrate binds to
one of the zinc ions while the scissile carbonyl group binds to
the other zinc ion. The bridging hydroxide then attacks the
carbonyl carbon of the peptide substrate to generate the gem-
diolate intermediate.
The aminopeptidase from Streptomyces griseus (sAP) be-
longs to the same family as aAP and blAP and is the fourth
AP to have its crystal structure resolved [18]. This AP shows
maximum activity at pH 8.0 and is speci¢c towards large
hydrophobic amino acids, preferably leucine. It requires two
zinc ions for activity [19^21], and its activity is signi¢cantly
enhanced by calcium [19,20]. The crystal structure reveals that
the zinc ions in the active site are 3.6 Aî apart [18], with one
zinc ion (Zn1) bound to His-85 and Asp-160 and the other
(Zn2) bound to Glu-132 and His-247 (Fig. 1). Ligands bridg-
ing the two zinc ions are Asp-97 and a non-protein ligand,
identi¢ed as dibasic phosphate. This phosphate was shown to
bridge the two metal ions by one oxygen with a second oxy-
gen bound to Zn1 (Fig. 1). The hydroxo group of this phos-
phate was suggested to interact with Glu-131 and Arg-202
near the active site.
To obtain a better understanding of the mechanism of sAP
and how phosphate interacts with sAP, phosphate inhibition
was examined at di¡erent pH values. In addition, £uoride
inhibition was performed to provide insight into the role of
the coordinated water molecule that was not revealed in the
crystal structure.
2. Materials and methods
The crude enzyme mixture Pronase, the bu¡ers TAPS (N-tris[hy-
droxymethyl] methyl-3-aminopropane sulfonic acid), HEPES (N-[2-
hydroxyethyl] piperazine-NP-2-ethanesulfonic acid) and MES (2-[N-
morpholino]ethanesulfonic acid), NaH2PO4WH2O, EDTA (ethylenedi-
amine tetraacetic acid), 1,10-phenanthroline, and the substrate L-leu-
cine-p-nitroanilide (Leu-pNA) were purchased from Sigma Chemical
Co. (St. Louis, MO). Diethylaminoethyl (DEAE) Sephacel and Sepha-
dex G-50 were used for puri¢cation of the protein and were also
purchased from Sigma. Zinc(II) stock solutions were prepared from
atomic absorption standard purchased from Fisher (Pittsburgh, PA).
All the solutions were prepared from deionized water of s 18 M6
from a MilliQ system (Millipore, Bedford, MA). The glassware and
plastic ware were treated with EDTA and rinsed with deionized water
prior to use.
S. griseus aminopeptidase was prepared according to the literature
procedure [19,20]. The enzyme concentration was determined accord-
ing to the absorption value E1%280 = 15 [19,20]. Kinetic measurements
were performed on a Cary 3E spectrophotometer using the substrate
Leu-pNA from pH 5.5 to 9.0 at 30‡C. Assays were performed in
50 mM bu¡er in the presence of 60 mM NaNO3 and 0.1 mM
Zn2. Both NaNO3 and NaCl below 0.5 M were found not to a¡ect
the enzyme activity. The initial rate of the hydrolysis of the substrate
was obtained by monitoring the release of the chromophore pNA at
405 nm (O= 10 600 M31 cm31 which is found constant in the pH range
of 5.5^9.0) [19,21]. The kinetic parameters kcat and Km were obtained
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by non-linear ¢tting of data to the hyperbolic Michaelis-Menten equa-
tion. The substrate was ¢rst dissolved in a minimum amount of di-
methyl sulfoxide (DMSO), then dissolved in a bu¡er at the desired
pH. The amount of DMSO in the solutions showed no inhibitory
e¡ect on sAP under the experimental conditions. The enzyme concen-
tration was 7.0 nM for the entire pH study and the phosphate con-
centration varied to a¡ord the inhibitor constant. To test our meth-
ods, assays were compared to the literature values [19^21]. The results
showed a Km of 0.54 mM and a kcat of 396 s31 in the presence of 1.0
mM Ca2, in good agreement with the previous results.
3. Results and discussion
3.1. Phosphate inhibition
Phosphate has been used extensively as a probe to study
active sites of metalloproteins and has been shown to bind
positively charged residues such as lysine and arginine [22^
24]. Crystallographic study of sAP also suggested that phos-
phate is bound to this enzyme [18]. In order to elucidate if
mechanistic information could be obtained from phosphate
binding to sAP, the inhibitory nature of phosphate was inves-
tigated in the pH range of 5.85^9.0. Non-competitive inhib-
ition was observed at every pH tested in this study. The in-
hibitor constant (Ki) increased from 0.48 þ 0.06 mM at pH
5.85 to 110 þ 1.7 mM at pH 9.0. Only very weak inhibition
was observed at pH 10. The AP activity can be completely
recovered when phosphate is removed by ultra¢ltration, indi-
cating the enzyme is intact during the inhibition. A represen-
tative result is shown in Fig. 2 as plots of 1/rate versus 1/[S] at
pH 7.5.
Purely non-competitive inhibition and partially non-com-
petitive inhibition can be distinguished by plotting rate versus
[I] (inset, Fig. 2) [25]. For purely non-competitive inhibition
the rate approaches zero at high inhibitor concentrations,
whereas the curve for partial non-competitive inhibition
reaches a limiting velocity. In other words, the substrate-in-
hibitor complex cannot convert to products in purely non-
competitive inhibition. In addition, the plots of 1/Vmaxi versus
the concentration of phosphate yielded a linear correlation at
every pH in this study (data not shown), indicating that the
enzyme has only one phosphate binding site [25].
The nature of the phosphate inhibition and the crystal
structure assignment of the zinc-bound phosphate present a
controversial situation. The non-competitive kinetics in this
study indicate that phosphate and the substrate bind at di¡er-
ent sites, thus tetrahedral phosphate cannot bind to the metal
center as a transition-state analog. However, the crystal struc-
ture of sAP reveals that phosphate bridges both Zn ions by
one oxygen, with another oxygen bound only to Zn1 (Fig. 1).
This phosphate binding mode is similar to that of transition-
state analogues bound to blAP with one bridging and one
terminal oxygen bound to the dinuclear active site [14^17],
and the aAP-inhibitor complex with one bridging oxygen
[9]. If phosphate did bind to sAP in solution as it is shown
in the crystal structure, at least a mixed type of inhibition
would be expected in which the enzyme-inhibitor complex
has a lower a⁄nity than the free enzyme for the substrate
[25]. This was not observed in our study. The justi¢cation
Fig. 1. Structure of the di-zinc active site in S. griseus aminopepti-
dase with the bound phosphate [18], Protein Data Bank code 1xjo.
Fig. 2. The plot of 1/V (Wmol/s)31 versus 1/[S] mM31 at pH 7.5 for
phosphate inhibition, in which the lines intersect on the x-axis char-
acteristic of non-competitive inhibition. Phosphate concentrations
are 0.0 (b), 5.0 (F), 20 (R), and 50 (S) mM. The inset is a plot of
V (Wmol/s) versus [phosphate] at pH 5.85, at which phosphate
exhibits the highest inhibition in this study. The solid line is a
¢tting toward the equilibrium with only one phosphate bound. The
rate at s 140 mM phosphate is beyond detection limits under the
experimental conditions within 20 min.
Fig. 3. The plot of 1/V (Wmol/s)31 versus 1/[S] mM31 at pH 7.0 for
£uoride inhibition, in which the parallel lines are indicative of un-
competitive inhibition. Fluoride concentrations are 0.0 (b), 20 (F),
40 (R), and 80 (S) mM. The inset is a plot of 1/Kmapp versus [£uo-
ride] (mM) at pH 7.0, in which the linear relationship indicates that
sAP binds only one £uoride ion.
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of a bound dibasic phosphate (rather than a sulfate) in the
crystal structure is based on phosphate’s acidity relative to
sulfate, in which a hydroxyl group is present in phosphate
that can interact with Glu-131 and Arg-202 [18]. However, a
region near the active site (Glu-196 to Arg-202) could not be
traced in the crystal structure due to poor electron density,
which could have posed a problem in the assignment of the
phosphate interactions.
Phosphate has been shown to bind to arginine in enzymes
such as copper-zinc superoxide dismutase [24,26], ribonuclease
A [27], and several others [28]. Moreover, arginine has been
implicated as a residue essential to the function of a number
of enzymes [24^29], such as the above enzymes, carboxypep-
tidase A [30], and glutamine synthetase [31], which become
inactive or signi¢cantly decrease in activity once their arginine
residues are chemically modi¢ed. The crystallographic study
of sAP suggests that an arginine residue (Arg-202) is located
near the active site [18]. Based on our study phosphate does
not bind directly to the zinc ions in sAP, therefore it is sus-
pected that the phosphate binding site is Arg-202. This argi-
nine may play a critical role in the action of sAP, likely to be
involved in hydrogen bonding and/or acting as a general acid
during the hydrolytic process.
3.2. Fluoride inhibition
Fluoride has been utilized to probe metal-bound water or
hydroxide in several metalloproteases [32^38], thus has been
chosen as a probe to study the status of the coordinated water
in sAP. The kinetic data clearly show that F3 uncompetitively
inhibits the hydrolysis in the pH range of 5.5^9.0 (Fig. 3). The
apparent 1/Km versus [F3] plot shows a linear relationship,
which indicates that F3 is a pure uncompetitive inhibitor and
the enzyme binds only one F3 [25] (inset, Fig. 3). The inhib-
itor constant (Ki) is 3.72 þ 0.25 mM at pH 5.5 and increases to
43.6 þ 0.8 mM at pH 9.0. This uncompetitive inhibition nature
re£ects that the inhibitor can bind to the enzyme only after
the substrate is bound, suggesting that a water/hydroxide be-
comes available for F3 substitution after substrate binding.
One possibility is a change from bridging to terminally bound
hydroxide that becomes replaceable. Fluoride was shown to
be an uncompetitive inhibitor towards Leu-pNA hydrolysis by
aAP [12]. It was proposed that a zinc bound hydroxide was
substituted by F3 and that this hydroxide was supposedly the
attacking nucleophile. This is also likely the case in sAP.
3.3. pH dependence of phosphate and £uoride inhibitions
The pH dependence of phosphate and £uoride inhibitions is
shown in Fig. 4. A pKa of 7.1 is obtained for phosphate
inhibition from non-linear regression ¢tting of the data.
This pKa is consistent with that of ionization of H2PO34 , re-
ported at 7.12 at 25‡C [39]. The pH dependence of F3 inhib-
ition reveals a pKa of 6.2. Fluoride is expected to bind hard
acids such as Zn2 based on the hard/soft concept of acids
and bases [40]. A pH dependence study of sAP activity also
reveals a similar pKa of V6.0 in the kcat versus pH plot,
suggested to be due to ionization of a coordinated water
(H.I. Park and L.-J. Ming, unpublished observation). On
the basis of the uncompetitive pattern of F3 inhibition, the
pH dependence of this inhibition, and pH-activity pro¢le, we
propose that the binding of F3 is associated with the displace-
ment of a catalytically signi¢cant coordinated water/hydrox-
ide that has a pKa of 6.2.
4. Concluding remarks
Crystallographic studies of transition state analogs with
blAP and aAP suggest that the zinc ions function in the bind-
ing and polarization of the substrate [9,14^17]. The phosphate
inhibition study clearly shows that phosphate and the sub-
strate bind to sAP at di¡erent locations. Therefore, the bind-
ing of phosphate to sAP in solution cannot be the same as
that proposed from the crystal structure. This conclusion is
supported by our preliminary 31P NMR studies of phosphate
binding to CoZn-sAP, which do not suggest direct phosphate-
metal interaction. A detailed investigation of phosphate bind-
ing to the Co2 derivative of sAP by the use of NMR is in
progress. Fluoride inhibition has provided insight into a zinc-
bound coordinated water of sAP. The uncompetitive inhibi-
tion pattern of F3 towards sAP is similar to that observed in
aAP and can suggest possible mechanistic similarities between
the two enzymes despite their low sequence homology (24% in
aligned regions) [8,18] and very di¡erent functional groups in
the proximity of the active site zinc ions.
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